Response-Guided Neoadjuvant Chemo Beneficial in Breast CA A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ...
A multicenter American College of Radiology Imaging Network trial has determined that breast lesions categorized as BI-RADS 3 or probably benign have low malignancy rates, suggesting that follow-up ...
Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be ...
According to ARRS' American Journal of Roentgenology (AJR), returning to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, ...
OAK BROOK, Ill. - Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that ...
Expression of GHRH-R in primary and metastatic mammary carcinomas. This is an ASCO Meeting Abstract from the 2014 Breast Cancer Symposium. This abstract does not include a full text component.
OAK BROOK, Ill. – Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results